EssilorLuxottica: Sight To Behold
What this covers
Swetha and Zack take apart EssilorLuxottica, the product of the 2018 merger of lens maker Essilor and frame maker Luxottica, later extended by the 2019 GrandVision purchase. The business splits roughly 75% prescription lenses and 25% frames and sunglasses, and the episode keeps contrasting the two. Lenses are close to a necessity, with the company holding almost 55% of the market against Hoya and Carl Zeiss. Frames and sunglasses are fragmented, with a bit over a third share and a long tail of rivals. The financial crisis is used as a test case, tied to the Lipstick Effect and to necessity versus discretionary demand.
The history gets real attention. It covers the post-merger power struggle between Leonardo Del Vecchio and Hubert Sagnières, which ran through arbitration until a 2019 settlement, and the dilutive GrandVision deal, which forced the divestiture of about 350 stores. A contested point is whether the family control that European firms are criticized for is what makes long-horizon investment possible. Another is whether going fully direct-to-consumer works: Nike and Adidas stumbled, and Warby Parker is dismissed as a me-too player. The open network, where rivals such as Hoya and Kering Eyewear are also suppliers or customers, is set against closed models like Zara.
The numbers are where the discussion turns skeptical. On about €26.5 billion of revenue, EBIT is roughly 16%, because selling costs from some 18,000 stores absorb half the gross margin. A gross margin of 63-64% suggests moderate pricing power. Growth drivers include rising myopia and the Ray-Ban Meta glasses, at about 2 million units sold. The antitrust worry is judged overstated.
EssilorLuxottica's moat comes from vertical integration across lenses, frames, and retail, with scale funding R&D, and the company's margin potential is capped by its retail-heavy cost base and by its partnership-dependent smart glasses strategy.
- Scale and vertical integration fund R&D and distribution, and an open network lets competitors act as customers
- Prescription lenses are a concentrated, non-discretionary oligopoly while frames and sunglasses are fragmented and cyclical
- Targeted 19-20% EBIT margin looks optimistic given selling costs, reinvestment, and tariff risk
Open-network scale creates a self-reinforcing cycle that funds innovation rivals struggle to match.
- EssilorLuxottica is roughly three times the size of its closest competitor, Alcon, which operates in only a small segment of the eyewear value chain.
“it's three times the size of its closest competitor, which happens to be Alcon, which operates in a very small segment of the eyewear value chain”
- Scale from an open network lets EssilorLuxottica reinvest in stores and R&D, and that reinvestment strengthens its scale in a self-reinforcing cycle.
“that scale is a virtuous cycle that allows them to reinvest behind their stores, but also behind innovation and R&D.”
- EssilorLuxottica operates an open network in which competitors are also customers, such as Hoya supplying it and Kering Eyewear selling Gucci sunglasses through its retail network, unlike closed vertical models like Zara that sell only their own product.
“its own competitors are also its clients and customers because it has an open network framework”
- eCommerce accounts for about 7% of sales and roughly 20% of capex goes to digital technology, which Swetha sees as now table stakes in a retail-heavy business facing online competitors.
“I think this is now increasingly table stakes for a business like this which is facing competition”
- EssilorLuxottica holds over 12,000 patents pending or granted across more than 2,000 patent families and nearly 21,000 trademarks pending or registered, with over 50 lens researchers working on mold processing and optical technologies.
“They have over 12,000 patents pending or granted across more than 2,000 patent families. They have nearly 21,000 trademarks”
- R&D is only about 2% of sales, yet EssilorLuxottica outspends about three-quarters of the industry on R&D, suggesting rivals struggle to match the scalability of its innovation.
“R&D... is only about 2% of sales. And even with this, they are outspending about three-fourths of the industry.”
- Capital expenditure peaked at about 7% of sales and is expected to settle around 5%, with roughly a third going to operations and a third to retail, reflecting continued investment behind store productivity.
“CapEx, it has peaked at about 7% and steady state is expected to be about 5%.”
- Scale generates a virtuous cycle in which sales volume funds R&D and retail reinvestment, and the vertically integrated structure pushes innovation directly into its own distribution channels.
“that scale is a virtuous cycle that allows them to reinvest behind their stores, but also behind innovation and R&D.”
- Vertical integration lets the company push innovation directly into its own distribution channel, so R&D investment translates into proprietary IP and faster rollout across vision, design, and smart eyewear.
“their vertically integrated structure that also allows them to push that innovation into their own distribution channel.”
Smart glasses and hearing solutions are the key growth bets, which delay the margin target.
- EssilorLuxottica's Nuance Audio hearing solution, sold over the counter in the US and through audiologists in Europe, is packaged in glasses to reduce stigma and targets mild-to-moderate hearing loss common in aging Western populations.
“you've got quality hearing solutions but in the form factor of glasses, and that minimizes the stigma.”
- Ray-Ban Meta, launched in October 2023, is the only connected glasses product to reach mass-market adoption so far, with 2 million units sold, and it could follow the smartwatch path if it goes mainstream.
“the Ray-Ban Meta, which launched in October 2023, has really been the only connected glass option to reach mass-market adoption. They just said that they have sold 2 million units”
- EssilorLuxottica needs Meta AI to power its smart glasses, and Meta needs EssilorLuxottica's brands and distribution, but the economic split of Meta Ray-Ban sales is undisclosed and the partnership depends on how successful Meta AI becomes.
“this is sort of a symbiosis where both companies do need each other.”
- EssilorLuxottica paid $1.5 billion for Supreme from VF Corp in 2024, a price below what VF paid, and the rationale is likely to use Supreme as a brand vehicle to popularize smart glasses among younger, Asian, Gen Z consumers, since hats and T-shirts alone would not justify the price.
“I believe the reason for doing this deal is that over time they will seek to do a version of the Meta Ray-Ban with Supreme as well.”
- The company targets an EBIT margin of 19-20% by the end of FY2026, but Swetha expects this to be delayed because growth investments in smart glasses and hearing aids will take priority.
“It's my personal impression that that is likely to be delayed because their first priority will be to invest in growth.”
Prescription lenses form the concentrated, less cyclical, more profitable core of the business.
- About 75% of EssilorLuxottica's revenue comes from vision care and prescription lenses, while frames and sunglasses make up roughly 25%, and lenses are the more profitable side.
“75% of their business today is actually from vision care. It's from corrective lenses.”
- EssilorLuxottica holds almost 55% of the prescription lens market, with Hoya and Carl Zeiss as the main other players, making lenses an almost oligopolistic and more concentrated market than frames.
“EssilorLuxottica has over 50%, almost a 55% share of this market. ... It's almost an oligopoly.”
- Prescription lenses are a near necessity for over 4 billion people, and insurance or employer coverage of eye exams stabilizes demand, so the lens business is much less cyclical than the frames and sunglasses business.
“prescription lenses, they're really a necessity for over 4 billion people worldwide. It's not quite a discretionary product in some cases.”
- In frames and sunglasses EssilorLuxottica holds just over a third share, with Kering Eyewear around 10% and Safilo around 7%, and the fragmented tail of other players makes up about 40% of that market versus only 3% of prescription lenses.
“the other end of the market, which is a real fragmented tail, constitutes only 3% of the market for prescription lenses. But actually it makes up about 40% of the market for frames and sun.”
Weak core lens pricing power limits margin expansion, and antitrust concerns are overstated.
- EssilorLuxottica makes 550 million prescription lenses a year, which covers just over 5% of the world's population, and at an estimated average of about €200 per consumer per year it reaches only around 113 million consumers, so its sales are volume-driven rather than high-value.
“they may be reaching only 113 million consumers a year”
- EssilorLuxottica's gross margin has stayed at about 63-64% for five years and management does not guide to material uplift, which places its pricing power between luxury brands above 80% gross margin and footwear in the 50s, meaning pricing power is moderate and some price elasticity should be expected.
“That suggests to me that pricing power is moderate, but that you should expect some price elasticity given the market fragmentation and greater substitutability.”
- Because the market is fragmented and entry barriers are low, consumers have respectable substitutes and are not being gouged, although EssilorLuxottica's scale gives it procurement efficiencies that partly offset this.
“There are perfectly respectable and serviceable substitutes out there in the market because of how fragmented it is, because of how relatively low the barriers to entry are.”
- On revenue of about €26.5 billion, EBIT is under €3.5 billion, roughly a 16% margin, because about half of the gross margin is absorbed by selling expenses from a network of roughly 18,000 retail stores and nearly 200,000 employees.
“half of that gross margin is selling expenses. And we must remember that they have a huge network of retail stores—roughly 18,000 retail stores”
- Innovation can justify premium pricing in eyewear, as with Nuance hearing aids possibly retailing around $1,500 OTC and Stellest slowing myopia progression in children, similar to pharma pricing power, though core lens pricing power is weak.
“the Nuance hearing aid technology could retail for about $1,500... Stellest, which is their offer to actually arrest myopia in young children”
- There is no evidence EssilorLuxottica abuses pricing power in its core lens business, and it is hard to argue it exploits consumers when about 40% of the frames market sits with smaller players.
“There are perfectly respectable and serviceable substitutes out there in the market because of how fragmented it is, because of how relatively low the barriers to entry are.”
- A 33% share of frames and sunglasses does not indicate dominance, EssilorLuxottica's own stores sell competitor brands, and the category has so many options that it lacks meaningful pricing power, so the antitrust concern is overstated.
“if we just look at the objective facts, they have a 33% share of frames and sunglasses. That doesn't suggest to me that they're so dominant.”
Myopia, uncorrected vision impairment, and aging populations sustain growing demand for eyewear.
- Myopia affects more than 2 billion people and is expected to affect about 5 billion, or half the world's population, by 2050, with the highest rates in young children in China and India, so penetration of corrective eyewear should keep rising especially in emerging markets.
“By the year 2050, it's expected that 5 billion people, or half of the world's population, will be shortsighted.”
- Uncorrected vision impairment may cost the global economy more than $300 billion a year in lost productivity, and about 90% of cases in developing economies at the bottom of the income pyramid remain undiagnosed.
“uncorrected vision impairment today might cost the global economy north of 300 billion dollars in lost productivity”
- Asia is currently smaller than North America and Europe, but has the greatest upside because children there have the highest myopia prevalence and the channel is dominated by brick-and-mortar and eCommerce rather than independents.
“with huge optionality in terms of upside, given that children in Asia are most in need of corrective lenses”
- North America is the largest region at roughly €35 billion with over half of revenue through independent eye care, EMEA has about 59% independent channel, and Asia Pacific relies more on brick-and-mortar retail and eCommerce, with EMEA being slightly larger than North America.
“the independent eye care channel is much more important in North America. It's actually over half of their revenues come from the independents”
- Aging populations, population growth, and rising incomes driving penetration in emerging markets are durable, sustainable long-term growth trends for eye care.
“all of those are durable and sustainable trends for the long term”
Multi-brand retail, not single-brand digital models, drives margins and customer choice.
- Warby Parker's model of owning the customer experience while outsourcing manufacturing did not produce sustained profits, and its sales are about 2% of EssilorLuxottica's, so it has become a me-too player rather than a true disruptor.
“they've actually struggled to turn a profit. And if you contrast that to EssilorLuxottica at 16% EBIT margins”
- Warby Parker's single-brand focus, once a strength, has become a weakness because consumers, especially after the pandemic, want choice across many brands, which EssilorLuxottica can offer across its 150 brands and third-party frames at retail.
“consumers, especially post-pandemic, have voted with their feet in that they want choice”
- EssilorLuxottica's EBIT margin is now about 16%, roughly double the just-above-half-of-this level it was seven or eight years ago, which Swetha attributes largely to the multi-brand retail channel.
“margins which are now at 16% versus just above half of this about seven or eight years ago”
- Vertical integration unlocks value for low-margin businesses but does not always work, as Nike and Adidas found when their post-pandemic push to go fully direct-to-consumer and drop wholesale failed because consumers want multi-brand environments.
“vertical integration is the key to unlocking value, and it doesn't work all the time. We saw this end quite badly post-pandemic for, say, brands like Nike and Adidas”
- Warby Parker's digital-first model, which outsourced manufacturing and controlled design and retail, succeeded during the pandemic but has struggled to turn a profit, in contrast to EssilorLuxottica's 16% EBIT margins.
“that digital-first model was a huge success during the pandemic, but they've actually struggled to turn a profit.”
AI integration, not hardware alone, makes smart glasses viable for mass adoption.
- EssilorLuxottica is building capacity to sell up to 10 million Meta Ray-Ban units after selling 2 million last year, pricing them at around $300 in the US to drive adoption before competitors arrive.
“It's priced surprisingly affordably at just about $300 a pair at retail in the US”
- Smart glasses are a roughly $3 billion market against about $34 billion for smartwatches, and the gap reflects that AI, not the hardware form factor alone, is the key unlock, which is why Meta AI in Ray-Ban is fundamentally different from the early Ray-Ban Stories.
“AI is the key unlock here. And so Meta AI powering Ray-Bans is a fundamentally different proposition from the old Ray-Ban Stories 1.0”
- Google Glass and the first Ray-Ban Stories did not take off, but EssilorLuxottica kept iterating until AI integration in Meta Ray-Ban made the proposition work, showing that persistence in new categories can pay off.
“So the question of continuing to tweak that proposition until the consumer readiness is there is something that has come to this company quite naturally”
- The relaunch of Meta Ray-Ban glasses with Meta AI, unlike the earlier Ray-Ban Stories, made smart glasses ready for mass adoption, with about 2 million units sold, and the smart glasses hype has lifted EssilorLuxottica's valuation.
“the relaunch of Meta Ray-Ban, because of the integration of Meta AI—which did not exist in the earlier iteration of Ray-Ban stories—has really made this popular and ready for takeoff.”
Merger governance conflict and costly acquisitions were settled in 2019, and controlled governance underpins growth.
- The July 2019 GrandVision acquisition, valued at just over €7 billion against EssilorLuxottica's roughly €50 billion market cap, was highly dilutive and required the European Commission to force divestiture of about 350 stores in Belgium, Italy, and the Netherlands.
“this deal was valued at just over 7 billion euros... a hugely dilutive deal”
- After the 2018 merger, a prolonged public governance fight between Del Vecchio and Hubert Sagnières over power, including arbitration, hurt morale, the share price, and investor credibility in management until a 2019 settlement.
“There was a very long and publicly drawn-out battle in terms of corporate governance over 2018–2021 and these splits.”
- A 2019 settlement ended the governance fight, leaving Francesco Milleri as the official CEO with Paul du Saillant as deputy CEO, which removed distraction and eased the share price pressure.
“reach a settlement agreement to overcome these governance issues. This happened in 2019.”
- Under EssilorLuxottica, Ray-Ban was transformed from a neglected Bausch & Lomb brand into a business with over €3 billion in annual revenue over roughly 15 years, a process that took decades in its original history too.
“they transformed a struggling brand into a 3 billion plus annual revenue powerhouse. I mean it did take them 15 years”
- Public governance battles like the 2018-2021 boardroom fight distract from the investment thesis and internal management focus, so leadership disputes should be resolved privately.
“don't air your dirty laundry in public. Because that corporate governance boardroom battle”
- Luxottica walked away from acquiring Safilo in 2009 because the deal did not make financial sense, showing a disciplined approach that balances seizing opportunities with knowing when to say no.
“they decided against it because it didn't make financial sense”
- Heavy family control and shareholding in European businesses are often criticized, but they allow long-term investment decisions that would otherwise be impossible, as exemplified by visionaries like Del Vecchio and Bernard Arnault.
“that has also allowed these businesses on many occasions to take very long-term investment decisions”
- Luxottica reignited dusty, forgotten brands like Ray-Ban and built growth through acquisitions such as Ray-Ban and Oakley, plus licenses for luxury brands like Chanel and Prada, making it the brand-building half of the merger.
“its ability, for example, to take these dusty, forgotten brands like Ray-Ban and really reignite and catalyze growth for those.”
Complexity costs and tariff risk cap sustainable margins below the 20% target.
- Given complexity and tariff risk, Swetha thinks EssilorLuxottica's sustainable EBIT margin is mid- to high-teens rather than the 20% target it is pushing for, and tariffs could add pressure.
“That's why maybe the mid-teens margin is actually fair. Mid- to high-teens. I'm really not sure that that 20% target”
- Advertising is about 7% of sales due to competition in frames and sunglasses, and general and administrative costs run about 8% of sales, which is high but partly justified by operating in 150 countries with a fully integrated value chain.
“that is about 7% of sales. And then here, they do have a little bit, in my view, of general admin bloat... which is about 8% of sales”
- Tariffs are a potential spanner in the works for EssilorLuxottica's margin ambitions, particularly for cross-border sales, though the speaker hopes they are transitory.
“And of course, we haven't even touched on tariffs yet. That could also be a potential spanner in the works of their margin ambitions.”
Vertical integration from manufacturing to customer was the rationale behind the 2018 merger.
- Leonardo Del Vecchio, then chairman and CEO of Luxottica, believed integrating and controlling every stage of the eyewear value chain was the key to unlocking value, and that conviction, plus the need to add lenses to Luxottica's frames and sunglasses, prompted the 2018 merger.
“he thought that integrating and controlling all aspects of the value chain in eyewear was the key to unlocking value”
- Essilor was the first manufacturer of the progressive lens in 1959, under the Varilux brand, an innovation that was highly influential and was followed by further innovations and acquisitions such as Transitions.
“Essilor was actually, all the way back in 1959, the first manufacturer of the progressive lens, which is Varilux”
- The 2018 deal was envisioned as a merger of equals with equal power sharing for three years and joint group CEO appointment afterward, with Del Vecchio agreeing to limit his larger voting rights, but cultural and governance differences between an Italian and a French company undermined the arrangement.
“this is an Italian company marrying a French company. Very different cultural profiles, governance, and managerial cultures as well.”
- Essilor never had direct-to-consumer distribution and relied on third-party wholesalers, so combining with Luxottica and GrandVision created an end-to-end manufacturing-to-customer model.
“what Essilor never had on its own was direct-to-consumer distribution. They had always relied on third-party wholesalers.”
Sub-brands, not the parent name, carry recognition, and brand acquisitions built the track record.
- EssilorLuxottica is a consumer health company whose name carries none of its brands, unlike LVMH, and its sub-brands such as Ray-Ban and Oakley are far more recognizable than the parent.
“this is a consumer health company where none of its brands actually have the honor of making it to the company name”
- Ray-Ban was acquired in 1999 for $640 million and became a huge hit, and Oakley was acquired in 2007 for $2.1 billion, establishing the brand-acquisition track record.
“Ray-Ban in 1999 for $640 million, which has been a huge hit, Oakley in 2007 for $2.1 billion”
- During the global financial crisis the standalone Essilor business kept growing and the sunglasses business declined only mid-single digits, which beat the wider luxury sector and fits a lipstick-effect pattern of affordable indulgence.
“the sunglasses business did experience some very moderate, though mid-single-digit, decline, which is somewhat better than what we saw elsewhere in the luxury industry.”
Smart glasses face competition and hype-driven valuation shifts.
- Meta has said it has approval to take a 5% stake in EssilorLuxottica, but neither company has confirmed whether the stake was actually acquired.
“Meta has said that they had approval to take a 5% stake in EssilorLuxottica. They haven't confirmed whether they have done it.”
- Smart glasses is an inherently competitive space where EllsorLuxottica's first-mover advantage may not persist, since Apple or rivals such as Sesame's AI glasses could win with superior functionality, and the company does not own the core AI technology.
“They have a first-mover advantage, but they may not be ultimately the winner in this space”
- The hype cycle around smart glasses has affected EssilorLuxottica's valuation in recent months, shifting the stock toward a technology narrative.
“the huge hype cycle around smart glasses, which, to no small extent, I think has impacted EssilorLuxottica's valuation in recent months”